Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
97.56 USD | +2.87% | +0.77% | -2.63% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- Low profitability weakens the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-2.63% | 2.31B | C+ | ||
-2.79% | 187B | C+ | ||
-2.09% | 106B | C | ||
-4.50% | 66.9B | A | ||
+0.81% | 49.45B | B- | ||
+16.62% | 48B | B- | ||
+4.06% | 40.84B | B+ | ||
+3.45% | 26.48B | B | ||
+1.04% | 26.25B | A- | ||
+12.96% | 24.62B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ICUI Stock
- Ratings ICU Medical, Inc.